Skip to main content
Clinical Trials/NCT04642196
NCT04642196CompletedNot Applicable

COVID-19 in Home Healthcare and Mortality

University Hospital, Linkoeping1 site in 1 country155 target enrollmentStarted: May 2, 2020Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
155
Locations
1
Primary Endpoint
Frailty

Study Overview

Brief Summary

Assessment of cause of Death in home Healthcare residents in Östergötland County, Sweden, who had a positive COVID-19 diagnosis and died between March and September 2020.

Our aim is to evaluate the pattern of comorbidity and frailty in a group of individuals in home healthcare with positive COVID-19 diagnoses who had a fatal outcome, and a second aim is to assess the contribution of COVID-19 to those fatal outcomes.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Retrospective

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •adult (< 18 years) individuals and
  • •cared for in home healthcare in Östergötland county and
  • •positive COVID-19 diagnosis and
  • •diseased between March and September 2020

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Frailty

Time Frame: Up to one month before death

Frailty is classified i four groups: * None or mild frailty: no restrictions in daily life. * Moderate frailty: mobile and independent but unable to handle physically demanding activities or work. * Considerable frailty: able to perform activities of daily living but confined at times to bed or chair. * Severe frailty: unable to perform activities of daily living and/or confined to bed or chair. Dementia necessitating care.

Comorbidity

Time Frame: Up to one month before death

Comorbidity is classified in three Groups: none or mild comorbidity (0-1 diagnosis), moderate comorbidity (2 diagnoses), and severe comorbidity (3 or more diagnoses)

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
University Hospital, Linkoeping
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Lena Nilsson

Dr

University Hospital, Linkoeping

Study Sites (1)

Loading locations...

Similar Trials